Delivered by Innovate UK, the engagging Global Business Innovation Programme - MedTech and Diagnostics Singapore 2024 consists of a Get ready preparation phase, 5-day innovation visit to focus on Singapore, an exploitation workshop, and support from an Innovate UK innovation and growth specialist - helping your business to identify opportunities and develop innovation projects with partners in the country. 

Applications will be considered from a wide range of innovative MedTech & Diagnostics companies that focus on, but not limited to:

• Medical Technologies
• Diagnostics including but not limited to In Vitro Diagnostics (IVDs), Medical Imaging and Wearables.

Areas of focus that are not being considered are:

• Patient Management Software. Digital Health.
• Formulated Therapeutics (* therapeutic delivery devices may be considered)

The Global Business Innovation Programme is structured around three main phases and each business will have a designated Innovate UK innovation and growth specialist to support them for the duration of the offering, including developing an action plan to capitalise on the opportunities identified. The three main phases of the Global Business Innovation Programme are:-

Get ready for the market: In person pre-visit briefing workshop to build knowledge and understanding of the market and potential opportunities, including how to do business, cultural aspects, how to protect your IP and training on how to improve your pitch and articulate your value proposition.

Visiting the market: Explore the innovation opportunities first-hand through meeting with key companies and research organisations and potential collaborators and partners through pre-arranged meetings and organised matchmaking. 

Exploit the opportunity: An exploitation workshop and one-to-one support from an Innovate UK innovation and growth specialist to follow up and take advantage of the opportunities identified.